BioVex raised €24M in a Series C round in Oct 2003. The company is based in Oxton, UK. Investors in the round: ABN AMRO, Avalon Ventures, CLSA and 2 others. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
